Influence of HLA-DR on the phenotype of CD4+ T lymphocytes specific for an epitope of the 16-kDa α-crystallin antigen of Mycobacterium tuberculosis

被引:0
|
作者
Agrewala, JN [1 ]
Wilkinson, RJ [1 ]
机构
[1] Hammersmith Hosp, Imperial Coll,TB & Related Infect Unit, Sch Med, MRC Clin Sci Ctr, London, England
关键词
T lymphocyte; helper-inducer; tuberculosis; crystallin; epitope; HLA-DR antigen;
D O I
10.1002/(SICI)1521-4141(199906)29:06<1753::AID-IMMU1753>3.0.CO;2-B
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T helper phenotype may be influenced by cytokine milieu, the differential expression of costimulatory molecules, antigen dose, and by differences in affinity at the TCR-peptide-MHC interface. We investigated the latter hypothesis by examining the response of six HLA-DR-restricted CD4(+) T cell lines specific for the immunodominant and permissively recognized p91-110 epitope of the 18-kDa alpha-crystallin protein of Mycobacterium tuberculosis. Each line was generated from a sensitized HLA-DR-heterozygous donor and all proliferated when peptide was presented by autologous irradiated peripheral blood mononuclear cells. However, when HLA-DR-matched homozygous Epstein-Barr-Virus-transformed B cell lines (L-BCL) were used as peptide-presenting cells there was heterogeneity in the response. The most pronounced proliferative response, and the highest IFN-gamma secretion and cytolytic activity was stimulated by L-BCL expressing molecules (DRB1*0101, *1501 and *0401) with high affinity (IC50 < 10 mu M) for the 16p91-110 peptide. By comparison, IL-4 secretion or a lower proliferative response could occur when peptide was presented by alleles of high, or of intermediate (10 mu M < IC50 < 100 mu M) affinity. These data support the hypothesis that the host MHC can influence CD4(+) phenotype and have implications for subunit vaccination against tuberculosis.
引用
收藏
页码:1753 / 1761
页数:9
相关论文
共 50 条
  • [1] Cytokine profile, HLA restriction and TCR sequence analysis of human CD4+ T clones specific for an immunodominant epitope of Mycobacterium tuberculosis 16-kDa protein
    Caccamo, N
    Barera, A
    Di Sano, C
    Meraviglia, S
    Ivanyi, J
    Hudecz, F
    Bosze, S
    Dieli, F
    Salerno, A
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 133 (02): : 260 - 266
  • [2] Th0 to Th1 switch of CD4 T cell clones specific from the 16-kDa antigen of Mycobacterium tuberculosis after successful therapy:: lack of involvement of epitope repertoire and HLA-DR
    Caccamo, N
    Meraviglia, S
    Dieli, F
    Romano, A
    Titone, L
    Salerno, A
    IMMUNOLOGY LETTERS, 2005, 98 (02) : 253 - 258
  • [3] Identification of epitopes of Mycobacterium tuberculosis 16-kDa protein recognized by human leukocyte antigen-A*0201 CD8+ T lymphocytes
    Caccamo, N
    Milano, S
    Di Sano, C
    Cigna, D
    Ivanyi, J
    Krensky, AM
    Dieli, F
    Salerno, A
    JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (07): : 991 - 998
  • [4] Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4+ T lymphocytes
    Chaux, P
    Vantomme, V
    Stroobant, V
    Thielemans, K
    Corthals, J
    Luiten, R
    Eggermont, AMM
    Boon, T
    van der Bruggen, P
    JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05): : 767 - 777
  • [5] Human CD4+ T lymphocytes recognize a vascular endothelial growth factor receptor-2-derived epitope in association with HLA-DR
    Sun, Yuansheng
    Song, Mingxia
    Jaeger, Elke
    Schwer, Christina
    Stevanovic, Stefan
    Flindt, Sven
    Karbach, Julia
    Nguyen, Xuan D.
    Schadendorf, Dirk
    Cichutek, Klaus
    CLINICAL CANCER RESEARCH, 2008, 14 (13) : 4306 - 4315
  • [6] An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR
    Ayyoub, M
    Hesdorffer, CS
    Montes, M
    Merlo, A
    Speiser, D
    Rimoldi, D
    Cerottini, JC
    Ritter, G
    Scanlan, M
    Old, LJ
    Valmori, D
    JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (08): : 1225 - 1233
  • [7] Use of HLA-DR*08032/E7 and HLA-DR*0818/E7 tetramers in tracking of epitope-specific CD4+ T cells in active and convalescent tuberculosis patients compared with control donors
    Li, Yan
    Zhu, Yan
    Zhou, Lin
    Fang, Yimin
    Huang, Lirong
    Ren, Liangliang
    Peng, Yi
    Li, Yifen
    Yang, Fangfang
    Xie, Dan
    Tang, Wenzheng
    Zhang, Na
    Zhong, Qiu
    Lai, Xiaomin
    IMMUNOBIOLOGY, 2011, 216 (08) : 947 - 960
  • [8] HLA-DR Marks Recently Divided Antigen-Specific Effector CD4 T Cells in Active Tuberculosis Patients
    Tippalagama, Rashmi
    Singhania, Akul
    Dubelko, Paige
    Arlehamn, Cecilia S. Lindestam
    Crinklaw, Austin
    Pomaznoy, Mikhail
    Seumois, Gregory
    DeSilva, Aruna D.
    Premawansa, Sunil
    Vidanagama, Dhammika
    Gunasena, Bandu
    Goonawardhana, N. D. Suraj
    Ariyaratne, Dinuka
    Scriba, Thomas J.
    Gilman, Robert H.
    Saito, Mayuko
    Taplitz, Randy
    Vijayanand, Pandurangan
    Sette, Alessandro
    Peters, Bjoern
    Burel, Julie G.
    JOURNAL OF IMMUNOLOGY, 2021, 207 (02): : 523 - 533
  • [9] Characterization of HLA-DR- and TCR-binding residues of an immunodominant and genetically permissive peptide of the 16-kDa protein of Mycobacterium tuberculosis
    Caccamo, N
    Meraviglia, S
    La Mendola, C
    Bosze, S
    Hudecz, F
    Ivanyi, J
    Dieli, F
    Salerno, A
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (08) : 2220 - 2229
  • [10] ANALYSIS OF HUMAN T-CELL EPITOPES IN THE 19,000 MW ANTIGEN OF MYCOBACTERIUM-TUBERCULOSIS - INFLUENCE OF HLA-DR
    FAITH, A
    MORENO, C
    LATHIGRA, R
    ROMAN, E
    FERNANDEZ, M
    BRETT, S
    MITCHELL, DM
    IVANYI, J
    REES, ADM
    IMMUNOLOGY, 1991, 74 (01) : 1 - 7